Back
Bristol-Myers Squibb Company (BMY)
PharmaceuticalsBMY · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$57.94
+0.73%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$3.46
ROE
38.7%
Gross margin
72.0%
Debt/Equity
2.31x
Revenue growth
2.6%
Bristol-Myers Squibb Company — company intelligence
Earnings surprises
Q1 2026$1.58 vs $1.43 est+10.4%
Q4 2025$1.26 vs $1.13 est+11.9%
Q3 2025$1.63 vs $1.52 est+6.9%
Q2 2025$1.46 vs $1.08 est+35.0%
Insider activity · 90 days
0 buys2 sellsnet -4,475 shares
Haller Julia Aother 20,460 · Jun 15, 2026
Short Bartie WendySell 3,876 · Jun 3, 2026
Short Bartie Wendyother 8,040 · Jun 3, 2026
Recent SEC filings
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJul 2, 2026
Latest news
Will Myqorzo Drive Cytokinetics Higher Despite Competitive Pressure? — Yahoo · 17h ago
Pfizer Poised for Mixed Second Quarter, RBC Says — Yahoo · 19h ago
Start Investing At 60 And Retire On Dividends Forever — SeekingAlpha · 1d ago
PRTA Stock Rises Nearly 11% in Six Months: What's Driving It? — Yahoo · 1d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Bristol-Myers Squibb Company
Weekly undervalued picks (like BMY)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.